Sort
48,018 grants matching “immunotherapy”
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2024 · AI
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2022 · AI
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2023 · AI
Neonatal porcine islet xenografts for the treatment of type 1 diabetes
$1,090,894Allan D. Kirk · Duke University · U01 · FY2021 · AI
Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section
$1,090,698Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Development of a JBS HI-LO Urine DNA Kit
$1,090,481James Vincent Vowles · Jbs Science, Inc. · R44 · FY2018 · HG
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS
$1,089,572Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology
$1,088,982Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
RaceCAR-M immunotherapy for cancer and beyond
$1,088,500Denise J. Montell · University Of California Santa Barbara · DP1 · FY2025 · CA
RaceCAR-M immunotherapy for cancer and beyond
$1,088,500Denise J. Montell · University Of California Santa Barbara · DP1 · FY2024 · CA
A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy
$1,088,333Lena A. Basile · Neumedicines, Inc. · R44 · FY2015 · CA
Investigation of role of microbiota in development, progression and therapy of cancers
$1,088,170Amiran Dzutsev · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The Johns Hopkins Translational Science Team for the ET-CTN
$1,087,834Michael A. Carducci · Johns Hopkins University · UM1 · FY2016 · CA
SRC ON PRIMARY AND METASTATIC TUMORS OF THE CNS
$1,087,771Duke University · P50 · FY2001 · NS
PATHWAYS TO TOLERANCE IN HUMAN ISLET TRANSPLANTATION
$1,087,641University Of Miami School Of Medicine · R01 · FY2004 · DK
Center for Interventional Oncology
$1,087,597Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2017 · CA
Studies of human microbes and potential perturbations
$1,086,911Heidi Kong · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies
$1,086,648Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
CD40L BLOCKADE IN PEDIATRIC RENAL TRANSPLANTATION
$1,085,793Children'S Hospital Boston · U01 · FY2000 · AI
Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy
$1,085,460Michael Demetriou · Glytr Therapeutics, Inc. · R42 · FY2025 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,085,319Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Depletion, Repopulation and Tolerance in Sensitized Recipients
$1,085,214Stuart Johnston Knechtle · Duke University · U19 · FY2017 · AI
UCSF Project 1
$1,085,090Trever G Bivona · University Of California, San Francisco · U54 · FY2017 · CA
Functional Genomics of Sarcoma
$1,084,890Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Preclinical Development of First-in-Class GSTO1 Degraders for Colorectal Cancer
$1,084,396Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2025 · CA